OmniAb (OABI) Net Equity Issued and Repurchased (2024)

OmniAb (OABI) posted quarterly Net Equity Issued and Repurchased of $2.9 million for Q4 2024.

OmniAb (OABI) Net Equity Issued and Repurchased (2024) Analysis & Trends

OmniAb (OABI) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $2.9 million the latest figure, recorded in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 OmniAb 491.42 Mn 439.42 Mn 12.81 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.89 Mn
Dec 31, 2024 2.89 Mn